Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Coronary angioplasty 1987].

J M Juliard1, C Masquet, Y Baudouy

  • 1Service de Cardiologie, Hôpital Bichat, Paris.

Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|January 1, 1987
PubMed
Summary

Percutaneous transluminal coronary angioplasty (PTCA) offers a 90% immediate success rate for coronary artery disease. While restenosis occurs in 30% of cases, long-term follow-up shows two-thirds of patients remain asymptomatic.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Treatment of intrastent restenosis by drug eluting stents: experience from one cardiology centre].

Archives des maladies du coeur et des vaisseaux·2007
Same author

[Intracardiac echography].

Archives des maladies du coeur et des vaisseaux·2007
Same author

[Angioplasty of saphenous vein grafts in the acute phase of myocardial infarction. Short and mid-term results].

Archives des maladies du coeur et des vaisseaux·2004
Same author

[Myocardial infarction and disseminated lupus erythematosus].

Archives des maladies du coeur et des vaisseaux·2004
Same author

[Changes in reperfusion strategies in the acute phase of myocardial infarction from 1988 to 2001].

Archives des maladies du coeur et des vaisseaux·2003
Same author

[Femoral artery hemostasis after coronary angioplasty with moderate dose of heparin].

Archives des maladies du coeur et des vaisseaux·2003

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Context:

  • Percutaneous transluminal coronary angioplasty (PTCA) has become a standard treatment for coronary artery disease since its inception in 1977.
  • Indications for PTCA have expanded beyond symptomatic angina pectoris due to advancements in technology and techniques.

Purpose:

  • To review the efficacy and long-term outcomes of Percutaneous transluminal coronary angioplasty (PTCA) in managing coronary artery disease.
  • To highlight the evolving role and indications of PTCA in clinical practice.

Summary:

  • PTCA demonstrates a high immediate success rate of approximately 90% with a low mortality rate of 1%.
  • Restenosis remains a significant challenge, occurring in about 30% of patients within months, necessitating repeat procedures in nearly half of these cases.
  • Despite restenosis rates, long-term follow-up indicates satisfactory outcomes, with approximately two-thirds of patients remaining asymptomatic.

Impact:

  • The technique's immediate efficacy and favorable long-term results have driven a substantial increase in PTCA procedures over the past decade.
  • PTCA remains a crucial intervention for improving patient quality of life and managing ischemic heart disease.

Related Experiment Videos